1 completed, 1 withdrawn. 1 Not applicable, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Completed 1 |
| Phase 4 | 1 | Withdrawn 1 |
Follow Mark Frye: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Varenicline in Bipolar Depressed Patients Varenicline - Smoking, Bipolar Disorder | Not applicable | Completed | Mark Frye | 11 | 2009-01-01 | 2012-01-30 |
| Can Additional Drug Therapy Accelerate Response Time to Antidepressants citalopram + tiodothyronine, or + pindolol, or + placebo - Depression | Phase 4 | Withdrawn | Mark Frye | 2004-01-01 | 2015-06-01 |
Depression (2) · Bipolar Disorder (1) · Smoking (1)
Citalopram (1) · Pindolol (1) · Varenicline (1)
United States (2)
Mark A Frye, MD (1) · Mark A. Frye, M.D. (1)